LEPTIN DEFICIENCY GENE PANEL BY NGS, EDTA BLOOD

image not found

NABL Cap Accredited     
The Leptin Deficiency Gene Panel by NGS analyzes key genes involved in congenital leptin deficiency and severe early-onset obesity. This condition affects appetite regulation and metabolism due to genetic defects that impact leptin production or response. The test helps in diagnosing hereditary obesity syndromes, guiding early clinical management and personalized treatment options. Metropolis Healthcare uses advanced Next-Generation Sequencing technology to deliver accurate and reliable genetic results for better clinical decisions.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 21,000.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: L0143

Frequently Asked Questions (FAQ's):

What does the Leptin Deficiency Gene Panel test check for?
It detects genetic mutations associated with congenital leptin deficiency and related metabolic disorders.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced NGS sequencing to analyze specific genes linked to leptin signaling pathways with high precision.

Who should consider taking this test?
Children or adults with severe early-onset obesity, uncontrollable appetite, or a strong family history of obesity or metabolic syndrome.

What sample is required for the test?
A blood sample collected in an EDTA tube.

How long does Metropolis Healthcare take to provide results?
Typically within 2–3 weeks, depending on gene complexity and analysis requirements.

Does this test help in treatment planning?
Yes, test results may help clinicians decide on targeted therapies, lifestyle interventions, or hormone supplementation strategies.

Is genetic counseling available at Metropolis Healthcare?
Yes, Metropolis Healthcare offers professional counseling to help patients and families understand test results and implications.

Do family members also need testing?

In confirmed cases, Metropolis Healthcare may recommend testing close relatives for carrier or affected status 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab